From the Editor: Notable and Noteworthy
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Device... Read More
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. Read Less
Johnson & Johnson Company Stats
As of May 2024
- Industry
- Drugs & Biotechnology
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Country/Territory
- United States
- Chief Executive Officer
- Joaquin Duato
- Employees
- 131,900
Forbes Lists
#2
Net Zero Leaders (2024)
#342
Best Employers for New Grads (2024)
#24
Best Employers for Diversity (2024)
#173
America's Best Large Employers (2024)
#89
World's Top Companies for Women (2023)
#56
World's Best Employers (2023)
America's Best Employers By State (2023)
#112
Best Employers for Women (2023)
#40
Global 2000 (2023)
#94 - SALES
#56 - PROFITS
#213 - ASSETS
#15 - MARKET VALUE
#151
Canada's Best Employers (2023)Dropped off in 2024
#61
Mexico's Best Employers (2022)
#45
Just Companies (2021)
#63
Top Regarded Companies (2019)
#45
America's Largest Public Companies (2018)
Johnson & Johnson Financial Summary
Select list year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue
$96.3B
Assets
$196B
Profits
$12.7B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$94.9B
Assets
$182B
Profits
$19.8B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$82.6B
Assets
$174.9B
Profits
$14.7B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$82.8B
Assets
$155B
Profits
$17.2B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$81.6B
Assets
$153B
Profits
$14.7B
Revenue
$78.7B
Assets
$156.6B
Profits
$1.2B
Revenue
$71.9B
Assets
$141.2B
Profits
$16.4B
Revenue
$70.2B
Assets
$133.4B
Profits
$15.4B
Revenue
$74.2B
Assets
$131.1B
Profits
$16.3B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$71.3B
Assets
$132.7B
Profits
$13.8B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$67.2B
Assets
$121.3B
Profits
$10.9B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Revenue
$2.5B
Revenue
$61.6B
Assets
$102.9B
Profits
$13.3B
Sources
FactSet, Bloomberg, S&P Cap IQ; Forbes.
Johnson & Johnson (JNJ) Stock Price Performance
Johnson & Johnson (JNJ) Stock Key Data
SummaryAdditional DataAnalystsHistorical Quotes
Key Data
Previous Close
147.08
Open
146.53
Days Range
145.60 x 147.56
Volume
5,751,309
52 Week Range
143.13 x 175.97
Market Cap
$354.09B
P/E Ratio (ttm)
21.70
Forward P/E
13.97
Diluted EPS (ttm)
6.78
Dividends Per Share
4.76
Dividend Yield
3.37%
Ex-Dividend Date
May 20, 2024
Valuation Measures
P/E Ratio (ttm)
21.70
Forward P/E
13.97
Price to Sales (ttm)
4.27
Price to Book Value (ttm)
5.06
Price to Tangible Book Value (ttm)
N/A
Total Enterprise Value to EBIT (ttm)
15.33
Total Enterprise Value to EBITDA (ttm)
11.73
Total Enterprise Value to Total Revenue (ttm)
4.22
Profitability Metrics
Gross Margin (ttm)
69.34%
Operating Margin (ttm)
27.53%
Net Margin (ttm)
44.92%
Return on Assets (ttm)
8.01%
Return on Equity (ttm)
24.23%
Revenue and Earnings Metrics
Revenue (ttm)
$85.65B
Revenue Per Share (ttm)
34.48
Revenue Growth (y/o/y)
10.57%
EBITDA (ttm)
$30.61B
EBITDA Growth (y/o/y)
8.20%
Diluted EPS (ttm)
6.78
Diluted EPS Growth (y/o/y)
67.63
Cash and Debt Metrics
Total Cash
$26.22B
Total Cash Per Share
10.58
Total Debt
$33.63B
Total Debt/Equity
48.03%
Current Ratio
1.17
All values as of most recently reported quarter unless otherwise noted.
Consensus Recommendation
Outperform
Consensus Price
171.72
Range of Price Targets
155.00 to 215.00
Range of EPS
10.30 to 10.76
Consensus EPS
10.53
Consensus Revenue
$89.55B
Range of Revenue
$88.97B to $90.01B
- Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.
- EPS and Revenue estimates are for the next 12 months.
DATE | OPEN | HIGH | LOW | CLOSE | ADJUSTED CLOSE | VOLUME |
Jun 10, 2024 | 146.53 | 147.56 | 145.60 | 147.13 | 147.13 | 5,700,308 |
Jun 7, 2024 | 146.68 | 148.30 | 146.34 | 147.08 | 147.08 | 5,111,626 |
Jun 6, 2024 | 145.50 | 147.00 | 144.66 | 146.42 | 146.42 | 5,016,301 |
Jun 5, 2024 | 147.97 | 147.99 | 145.85 | 145.97 | 145.97 | 5,891,299 |
Jun 4, 2024 | 147.48 | 148.31 | 146.19 | 147.80 | 147.80 | 8,876,441 |
Jun 3, 2024 | 147.25 | 148.90 | 146.77 | 147.74 | 147.74 | 7,329,241 |
May 31, 2024 | 145.57 | 147.48 | 145.19 | 146.67 | 146.67 | 14,621,203 |
May 30, 2024 | 144.62 | 145.61 | 144.02 | 145.28 | 145.28 | 8,491,111 |
May 29, 2024 | 143.82 | 145.41 | 143.71 | 144.44 | 144.44 | 826,381 |
May 28, 2024 | 146.79 | 146.79 | 144.15 | 144.38 | 144.38 | 10,499,829 |
Related People & Companies
Johnson family
Company Stakeholder
Bartell Drugs
Related by Industry: Drugs & Biotechnology
New York Rangers
Located in New York-Northern New Jersey-Long Island, NY-NJ-PA Metropolitan Area
More on Forbes
2 minutes ago
Today’s ‘Wordle’ #1088 Hints, Clues And Answer For Tuesday, June 11th
Looking for help with today's New York Times Wordle? Here are hints, clues and commentary to help you solve today's Wordle and sharpen your guessing game.
ByErik KainSenior Contributor
39 minutes ago
New Tim Burton Docuseries Debuts At Tribeca Film Festival
Johnny Depp, Michael Keaton and Jenna Ortega are among the stars featured in a new docuseries about Tim Burton premiering Monday evening at the Tribeca Film Festival in New York City.
ByTim LammersContributor
52 minutes ago
Work-From-Home Levels Reach Lowest Since 2020—But Remote Work Still Dominates These Industries
The percentage of paid days worked from home in the U.S. dipped to 27% in May, following a consistent decline since mid-2022, according to WFH Research.
ByHyunsoo RimContributor
1 hour ago
Brewers Manager “Pessimistic” That Robert Gasser Will Return In 2024
As Robert Gasser prepares to get a third opinion on his left elbow, Brewers manager Pat Murphy is "pessimistic" about the rookie left-hander's chances of returning this season.
ByAndrew WagnerContributor
2 hours ago
Dana White Urges UFC Legend To Retire After Upcoming Bout
UFC CEO Dana White made a strong statement on the future of a future Hall-of-Famer, Tony Ferguson, no matter what happens in his upcoming bout in Abu Dhabi.
ByBrian MaziqueContributor
2 hours ago
FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug
The treatment would be the second of its kind to be authorized in the U.S. if it receives final approval.
ByAntonio Pequeño IVForbes Staff
3 hours ago
How To Watch UFC Vegas 93: Perez Vs Taira - Date, Start Time, Stream
The next fight card on the UFC schedule is Saturday's UFC Vegas 93: Perez vs. Taira. We have all the pre-event information you need for the upcoming fight card.
ByTrent ReinsmithContributor
3 hours ago
Noelvi Marte’s Imminent Return Will Boost The Cincinnati Reds
Reds third baseman Noelvi Marte is serving an 80-game suspension for performance enhancers. His return at the end of June could provide a needed jolt to their lineup.
ByDaniel R. EpsteinContributor
3 hours ago
Dan Hurley Spurns Lakers, Aims For UConn’s Third Straight NCAA Title
Dan Hurley turned down a lucrative offer from the Los Angeles Lakers to remain at UConn. He is looking to lead the Huskies to their third consecutive NCAA title.
ByTim CaseySenior Contributor
3 hours ago
‘Unacceptable Security Violation’: Elon Musk Says If Apple Integrates OpenAI In Its OS His Companies Will Ban Apple Devices
Musk threatened to make visitors at his companies leave their Apple products at the front, where they would be stored in a Faraday cage.
ByMolly BohannonForbes Staff
3 hours ago
Rhamondre Stevenson Believes He Is ‘Close’ To Contract Extension With Patriots
Rhamondre Stevenson nears the final year of his rookie contract with the New England Patriots. But an extension could soon arrive for the starting running back.
ByOliver ThomasContributor
3 hours ago
The First ‘Dragon Age: Veilguard’ Gameplay Clip Is Way Better Than That Horrible Trailer
The first gameplay reveal for 'Dragon Age: The Veilguard' looks great.
ByErik KainSenior Contributor
4 hours ago
Tim Burton On The Character He Most Identifies With In ‘Beetlejuice 2’
Tim Burton talks everything from his "Beetlejuice 2" inspiration to Netflix’s "Wednesday" starring Jenna Ortega and how it led to the “Beetlejuice” sequel.
ByTim LammersContributor
4 hours ago
How These Brew Brothers Bootstrap Seven Teas Into A Multimillion-Dollar Cultural Melange
Founded by brothers Jeremy and Josh Issakharian, Seven Teas has emerged as a brand that celebrates the rich, cultural tapestry interwoven with this age-old beverage.
ByDouglas YuSenior Contributor
May 30, 2024
Meet 2024's Net Zero Leaders
Forbes’ second annual Net Zero Leaders list highlights the 100 U.S. public companies that are best positioning themselves to reduce their greenhouse-gas emissions and ...
ByHeather NewmanSenior Contributor
May 14, 2024
Net Zero Leaders Methodology
To showcase companies that are leading the way to a carbon-neutral 2050, Forbes will publish its second-annual Net Zero Leaders list on May 30, 2024
ByAlan SchwarzForbes Staff